These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24656000)

  • 1. Uric acid is highly associated with kidney allograft survival in a time-varying analysis.
    Weng SC; Shu KH; Tarng DC; Cheng CH; Chen CH; Yu TM; Chuang YW; Huang ST; Wu MJ
    Transplant Proc; 2014; 46(2):505-10. PubMed ID: 24656000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperuricemia predicts kidney disease progression after acute allograft dysfunction.
    Weng SC; Shu KH; Wu MJ; Cheng CH; Chen CH; Yu TM; Chuang YW; Huang ST; Tarng DC
    Transplant Proc; 2014; 46(2):499-504. PubMed ID: 24655999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between serum uric acid levels at 3 months after renal transplantation and the graft outcome in living donor renal transplantation.
    Choi JY; Kwon OJ
    Transplant Proc; 2013 May; 45(4):1548-52. PubMed ID: 23726617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is uric acid a predictive factor for graft dysfunction in renal transplant recipients?
    Akgul A; Bilgic A; Ibis A; Ozdemir FN; Arat Z; Haberal M
    Transplant Proc; 2007 May; 39(4):1023-6. PubMed ID: 17524881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The independent association between serum uric acid and graft outcomes after kidney transplantation.
    Haririan A; Nogueira JM; Zandi-Nejad K; Aiyer R; Hurley H; Cooper M; Klassen DK; Weir MR
    Transplantation; 2010 Mar; 89(5):573-9. PubMed ID: 19997058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of uric acid with inflammation, progressive renal allograft dysfunction and post-transplant cardiovascular risk.
    Bandukwala F; Huang M; Zaltzman JS; Nash MM; Prasad GV
    Am J Cardiol; 2009 Mar; 103(6):867-71. PubMed ID: 19268747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A J-Shaped Association Between Serum Uric Acid Level and Allograft Outcomes After Living Donor Kidney Transplantation.
    Oh IH; Kim JE; Lee CH; Kim GH; Park JS
    Artif Organs; 2016 Feb; 40(2):136-43. PubMed ID: 26153484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperuricemia is associated with the development of the composite outcomes of new cardiovascular events and chronic allograft nephropathy.
    Akalin E; Ganeshan SV; Winston J; Muntner P
    Transplantation; 2008 Sep; 86(5):652-8. PubMed ID: 18791445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of early-onset hyperuricemia in renal transplant recipients.
    Chung BH; Kang SH; Hwang HS; Choi BS; Park CW; Kim YS; Kim JI; Moon IS; Yang CW
    Nephron Clin Pract; 2011; 117(3):c276-83. PubMed ID: 20847570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum uric acid level is associated with cardiac hypertrophy in renal transplant recipients.
    Caliskan Y; Gorgulu N; Yelken B; Akturk F; Yazici H; Turkmen A; Sever MS
    Clin Transplant; 2011; 25(3):368-74. PubMed ID: 20597927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can uric acid blood levels in renal transplant recipients predict allograft outcome?
    Isakov O; Patibandla BK; Shwartz D; Mor E; Christopher KB; Hod T
    Ren Fail; 2021 Dec; 43(1):1240-1249. PubMed ID: 34433378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elderly renal transplant recipients and renal dysfunction: a risk factor for hyperuricemia.
    Einollahi B; Einollahi H; Rostami Z
    Exp Clin Transplant; 2011 Dec; 9(6):376-80. PubMed ID: 22142044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uric acid contributes to glomerular filtration rate deterioration in renal transplantation.
    Kim KM; Kim SS; Yun S; Lee MS; Han DJ; Yang WS; Park JS; Park SK
    Nephron Clin Pract; 2011; 118(2):c136-42. PubMed ID: 21150221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperuricemia is a mediator of endothelial dysfunction and inflammation in renal allograft recipients.
    Karbowska A; Boratynska M; Kusztal M; Klinger M
    Transplant Proc; 2009 Oct; 41(8):3052-5. PubMed ID: 19857674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moderate-to-severe early-onset hyperuricaemia: a prognostic marker of long-term kidney transplant outcome.
    Min SI; Yun IJ; Kang JM; Park YJ; Min SK; Ahn C; Kim SJ; Ha J
    Nephrol Dial Transplant; 2009 Aug; 24(8):2584-90. PubMed ID: 19395726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperuricemia in adult renal allograft recipients: prevalence and predictors.
    Malheiro J; Almeida M; Fonseca I; Martins LS; Pedroso S; Dias L; Henriques AC; Cabrita A
    Transplant Proc; 2012 Oct; 44(8):2369-72. PubMed ID: 23026595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between serum uric acid level and heart failure and mortality in the early period of ST-elevation acute myocardial infarction.
    Gazi E; Temiz A; Altun B; Barutçu A; Bekler A; Güngör O; Yener AU; Kurt T; Ozcan S; Gazi S
    Turk Kardiyol Dern Ars; 2014 Sep; 42(6):501-8. PubMed ID: 25362938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperuricemia at 1 year after renal transplantation, its prevalence, associated factors, and graft survival.
    Numakura K; Satoh S; Tsuchiya N; Saito M; Maita S; Obara T; Tsuruta H; Inoue T; Narita S; Horikawa Y; Kagaya H; Miura M; Habuchi T
    Transplantation; 2012 Jul; 94(2):145-51. PubMed ID: 22728291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.
    Pietrzak-Nowacka M; Safranow K; Dziewanowski K; Debska-Slizień A; Głyda M; Gołembiewska E; Jankowska M; Nowosiad M; Rutkowski B; Ciechanowski K
    Ann Acad Med Stetin; 2008; 54(1):41-8. PubMed ID: 19127808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.